Dr. Anari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Philadelphia, PA 19111Phone+1 215-728-2500Fax+1 215-728-3639
Clinical Expertise
- Medical education
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2013 - 2016
Rutgers Robert Wood Johnson Medical SchoolClass of 2013
Certifications & Licensure
PA State Medical License 2013 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Comparison of Outcomes Between African American and European American Patients With Metastatic Clear Cell Renal Cell Carcinoma Receiving Immune Checkpoint Inhibitors.Jasmeet Kaur, Jill S Hasler, Elizabeth A Handorf, Matthew R Zibelman, Fern Anari
Clinical Genitourinary Cancer. 2025-04-01 - Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).Daniel M Geynisman, Philip H Abbosh, Eric Ross, Matthew R Zibelman, Pooja Ghatalia
Journal of Clinical Oncology. 2025-03-20 - Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of Cycles.Anumita Chakraborty, Jill Hasler, Elizabeth Handorf, Fern Anari, Pooja Ghatalia
Clinical Genitourinary Cancer. 2024-12-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
